DSC

DSC (DSC) is a company in Vietnam's Financial Services sector, listed on HOSE. The stock last traded at 9,900 VND, little changed on the session, giving a market capitalization of 3.4 trillion VND.

On valuation, DSC trades at a price-to-earnings ratio of 12.2 and a price-to-book of 1.1. That is a discount to the Financial Services sector average P/E of 31.3. Return on equity of 9.0% points to modest profitability relative to the company's equity base, above the sector average of 6.6%. Trailing earnings per share stand at 1,002 VND.

Aveluro tracks 5 news items mentioning DSC, where recent coverage skews positive (80% of articles). The most recent catalyst was a capital raise event — "Vidipha (VDP) Rights Offering: 10M Shares at 10,000 VND to Fund Cephalosporin Line". Aveluro's composite model rates DSC 5.9/10 (Neutral), blending news sentiment, price momentum, and fundamentals.

Comparable names in the Financial Services sector include AAS, ABW and AGR.

Recent developments around DSC include 4 notable classified events. On Jul 19, 2026, a market event was reported: Vidipha (VDP) will issue 9.94 million shares to existing shareholders at 10,000 VND/share, raising over 99.3 billion VND to invest in a Cephalosporin injection production line targeting EU-GMP standards. On Apr 22, 2026, an earnings beat was reported: DSC Securities reported Q1/2026 revenue of VND 184 billion, a 39.4% year-on-year increase, while pre-tax profit rose 7% to VND 72 billion. On Apr 18, 2026, a market event was reported: Capella Group becomes a major shareholder in DNSE Securities (DSE) with a 9.8% stake after acquiring 42.075 million shares through a rights issue that raised VND 1,275 billion. On Apr 16, 2026, a market event was reported: DSC Securities targets 2026 pre-tax profit of VND 356B (+3%) and revenue of VND 747B (+7%), both record highs, approved at its 2026 AGM.

The overall tone of recent coverage is positive, with 3 of 4 events carrying bullish sentiment.